Reid Hoffman Steps Down from Microsoft Board to Focus on AI-Powered Drug DiscoveryReid Hoffman Steps Down from Microsoft Board to Focus on AI-Powered Drug Discovery
TL;DR
- •Reid Hoffman is leaving Microsoft's board to fully dedicate himself to Manus, an AI-driven drug discovery startup.
- •Manus is focused on 'Move 37' AI – AI exceeding human creativity in chemistry, especially for cancer research.
- •Hoffman’s departure highlights the increasing pull of founder-led ventures in the rapidly evolving AI landscape.
source:
Read full post End of results for this topic.
